Related Experiment Video
Updated: Jul 23, 2026
08:34
Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Escherichia coli as a probiotic?
G J Jansen1, A C Wildeboer-Veloo, D van der Waaij
1Laboratory of Medical Microbiology, University of Groningen, The Netherlands.
Infection
|August 26, 1998
Summary
Oral treatment with Escherichia coli (E. coli) Symbio II did not alter gut microflora composition. However, it significantly boosted IgG antibody levels, indicating a specific immune response without modulating the gut microbiome.
Area of Science:
- Immunology
- Microbiology
- Gastroenterology
Background:
- The gut microbiome plays a crucial role in immune system regulation.
- Probiotic interventions, such as oral Escherichia coli (E. coli) supplements, are explored for their potential to modulate gut microbiota and immune responses.
- Understanding the specific effects of non-pathogenic E. coli strains on the human immune system is essential for therapeutic development.
Purpose of the Study:
- To investigate the impact of oral non-pathogenic Escherichia coli (E. coli) (Symbioflor II) on gut microflora composition.
- To assess the systemic humoral immune response, specifically IgG, IgA, and IgM isotypes, against E. coli cells following oral administration.
- To determine if Symbioflor II modulates the gut microbiome or elicits a specific immune response.
Main Methods:
- Ten healthy volunteers received oral E. coli (Symbioflor II) at 1x10^8 cells daily for 14 days after a 21-day pretreatment period.
- Gut microflora composition was analyzed morphologically.
- Systemic humoral immune response was measured using immune-fluorescence assays to quantify IgG, IgA, and IgM antibodies against E. coli.
Main Results:
- Oral E. coli (Symbioflor II) treatment did not result in any observable changes in the morphological composition of the gut microflora.
- Immune-fluorescence measurements showed a significant increase in circulating IgG antibodies specifically directed against the administered E. coli cells.
- No significant changes were noted in IgA or IgM levels against the E. coli cells.
Conclusions:
- Oral administration of non-pathogenic Escherichia coli (E. coli) (Symbioflor II) does not modulate the gut microflora in healthy individuals.
- The treatment induces a specific systemic humoral immune response, characterized by an increase in IgG antibodies against the administered E. coli.
- These findings suggest that Symbioflor II can elicit a targeted immune response without altering the overall gut microbial composition.
Related Concept Videos
01:29Bacterial Flora of the Large Intestine
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:27Microbiota of the Large Intestine
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
01:28Microbiota of the Urogenital Tract
The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...